[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note",
    "summary": "The latest trading day saw Johnson & Johnson (JNJ) settling at $144.62, representing a +0.89% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=7832f82998d3a9589dce1fad1afc41ce1e35870c4dd80432f886864e96970b77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735685119,
      "headline": "Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note",
      "id": 132220789,
      "image": "https://s.yimg.com/ny/api/res/1.2/gZA5XMnsr1RRZw6lGNAcdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NDA-/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The latest trading day saw Johnson & Johnson (JNJ) settling at $144.62, representing a +0.89% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=7832f82998d3a9589dce1fad1afc41ce1e35870c4dd80432f886864e96970b77"
    }
  },
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) Among the Best Low Volatility Stocks to Buy Right Now?",
    "summary": "We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best low volatility stocks to buy right now. The market has shown strong performance overall, with the S&P 500 up nearly […]",
    "url": "https://finnhub.io/api/news?id=4701cbef955c2893ca9936797fa0ac1d710f7f9d22e20c9ad3e8fcd5e0645058",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735671479,
      "headline": "Is Johnson & Johnson (JNJ) Among the Best Low Volatility Stocks to Buy Right Now?",
      "id": 132218406,
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best low volatility stocks to buy right now. The market has shown strong performance overall, with the S&P 500 up nearly […]",
      "url": "https://finnhub.io/api/news?id=4701cbef955c2893ca9936797fa0ac1d710f7f9d22e20c9ad3e8fcd5e0645058"
    }
  },
  {
    "ts": null,
    "headline": "Investors in Johnson & Johnson (NYSE:JNJ) have unfortunately lost 8.8% over the last three years",
    "summary": "For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...",
    "url": "https://finnhub.io/api/news?id=08dc8a23465e19442f65b6153f91e115a3a0e33b62dbbd85235fe97f88ba217b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735650013,
      "headline": "Investors in Johnson & Johnson (NYSE:JNJ) have unfortunately lost 8.8% over the last three years",
      "id": 132218407,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2eedc463aef15274c4887c130e30e298",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...",
      "url": "https://finnhub.io/api/news?id=08dc8a23465e19442f65b6153f91e115a3a0e33b62dbbd85235fe97f88ba217b"
    }
  },
  {
    "ts": null,
    "headline": "Here’s Why WisdomTree U.S. LargeCap Dividend Fund (DLN) Is One of the Best Performing Dividend ETFs in 2024",
    "summary": "We recently compiled a list of the 10 Best Performing Dividend ETFs In 2024. In this article, we are going to take a look at where WisdomTree U.S. LargeCap Dividend Fund (NYSE:DLN) stands against the other dividend ETFs. By the end of 2023, the global ETF market had reached $11.1 trillion in assets under management (AUM) […]",
    "url": "https://finnhub.io/api/news?id=e8c64d503b3d2a9869c224ffd6e8eef0fe4405f674b43240bf083e5fd241420d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735637439,
      "headline": "Here’s Why WisdomTree U.S. LargeCap Dividend Fund (DLN) Is One of the Best Performing Dividend ETFs in 2024",
      "id": 132218409,
      "image": "https://s.yimg.com/ny/api/res/1.2/4ko7YKOFINnXo.H8plWVIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/e3ecf53bec79d9efcbbf8d5ee65e09ac",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Best Performing Dividend ETFs In 2024. In this article, we are going to take a look at where WisdomTree U.S. LargeCap Dividend Fund (NYSE:DLN) stands against the other dividend ETFs. By the end of 2023, the global ETF market had reached $11.1 trillion in assets under management (AUM) […]",
      "url": "https://finnhub.io/api/news?id=e8c64d503b3d2a9869c224ffd6e8eef0fe4405f674b43240bf083e5fd241420d"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson - European Commission approves RYBREVANT in combination with LAZCLUZE for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer",
    "summary": "BEERSE, BELGIUM - Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission has approved a Type II variation extension of indication for RYBREVANT , in...",
    "url": "https://finnhub.io/api/news?id=390b8034457c7b48ce3cbbe72b765621fc925c8a2c08c3f2c07cf4a1507bf9e7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735627152,
      "headline": "Johnson & Johnson - European Commission approves RYBREVANT in combination with LAZCLUZE for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer",
      "id": 132212828,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "BEERSE, BELGIUM - Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission has approved a Type II variation extension of indication for RYBREVANT , in...",
      "url": "https://finnhub.io/api/news?id=390b8034457c7b48ce3cbbe72b765621fc925c8a2c08c3f2c07cf4a1507bf9e7"
    }
  },
  {
    "ts": null,
    "headline": "Halozyme: Recent Approvals Alter My Appetite",
    "summary": "Halozyme's attempt to acquire Evotec was a bold move to diversify revenue, but was ultimately unsuccessful, impacting HALO's stock price. Read more here.",
    "url": "https://finnhub.io/api/news?id=c714bfa806708643506ee41b5cea12f5daccff8dfa36735e7e106da9f2c9de6f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735612879,
      "headline": "Halozyme: Recent Approvals Alter My Appetite",
      "id": 132210479,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/904136898/image_904136898.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Halozyme's attempt to acquire Evotec was a bold move to diversify revenue, but was ultimately unsuccessful, impacting HALO's stock price. Read more here.",
      "url": "https://finnhub.io/api/news?id=c714bfa806708643506ee41b5cea12f5daccff8dfa36735e7e106da9f2c9de6f"
    }
  }
]